vs

Side-by-side financial comparison of AVITA Medical, Inc. (RCEL) and Rumble Inc. (RUM). Click either name above to swap in a different company.

Rumble Inc. is the larger business by last-quarter revenue ($27.1M vs $17.6M, roughly 1.5× AVITA Medical, Inc.). AVITA Medical, Inc. runs the higher net margin — -66.0% vs -120.8%, a 54.8% gap on every dollar of revenue. On growth, AVITA Medical, Inc. posted the faster year-over-year revenue change (-4.3% vs -10.5%). AVITA Medical, Inc. produced more free cash flow last quarter ($-6.1M vs $-31.7M). Over the past eight quarters, AVITA Medical, Inc.'s revenue compounded faster (26.0% CAGR vs 15.2%).

Avita Medical is a clinical and commercial company developing and marketing a range regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are ReNovaCell, for Aesthetics and Plastic applications including skin trauma, and ReGenerCell for the treatment of chronic wounds. The Avita Medical regenerative product range is currently marketed in Europe, the Middle East...

Rumble is a Canadian-American online video platform, web hosting, and cloud services business headquartered in Toronto, Canada, with its U.S. headquarters in Longboat Key, Florida. It was founded in 2013 by Chris Pavlovski, a Canadian technology entrepreneur. Rumble's cloud services business hosts Truth Social, and the video platform is popular among American conservative and far-right users. Rumble has been described as "alt-tech".

RCEL vs RUM — Head-to-Head

Bigger by revenue
RUM
RUM
1.5× larger
RUM
$27.1M
$17.6M
RCEL
Growing faster (revenue YoY)
RCEL
RCEL
+6.2% gap
RCEL
-4.3%
-10.5%
RUM
Higher net margin
RCEL
RCEL
54.8% more per $
RCEL
-66.0%
-120.8%
RUM
More free cash flow
RCEL
RCEL
$25.6M more FCF
RCEL
$-6.1M
$-31.7M
RUM
Faster 2-yr revenue CAGR
RCEL
RCEL
Annualised
RCEL
26.0%
15.2%
RUM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
RCEL
RCEL
RUM
RUM
Revenue
$17.6M
$27.1M
Net Profit
$-11.6M
$-32.7M
Gross Margin
81.2%
5.5%
Operating Margin
-59.1%
-131.1%
Net Margin
-66.0%
-120.8%
Revenue YoY
-4.3%
-10.5%
Net Profit YoY
-0.3%
86.2%
EPS (diluted)
$-0.37
$-0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RCEL
RCEL
RUM
RUM
Q4 25
$17.6M
$27.1M
Q3 25
$17.1M
$24.8M
Q2 25
$18.4M
Q1 25
$18.5M
$23.7M
Q4 24
$18.4M
$30.2M
Q3 24
$19.5M
$25.1M
Q2 24
$15.2M
$22.5M
Q1 24
$11.1M
$17.7M
Net Profit
RCEL
RCEL
RUM
RUM
Q4 25
$-11.6M
$-32.7M
Q3 25
$-13.2M
$-16.3M
Q2 25
$-9.9M
Q1 25
$-13.9M
$-2.7M
Q4 24
$-11.6M
$-236.8M
Q3 24
$-16.2M
$-31.5M
Q2 24
$-15.4M
$-26.8M
Q1 24
$-18.7M
$-43.3M
Gross Margin
RCEL
RCEL
RUM
RUM
Q4 25
81.2%
5.5%
Q3 25
81.3%
-1.8%
Q2 25
81.2%
Q1 25
84.7%
-26.7%
Q4 24
87.6%
-14.2%
Q3 24
83.7%
-45.4%
Q2 24
86.1%
-58.8%
Q1 24
86.4%
-79.5%
Operating Margin
RCEL
RCEL
RUM
RUM
Q4 25
-59.1%
-131.1%
Q3 25
-53.6%
-113.6%
Q2 25
-60.5%
Q1 25
-63.9%
-153.5%
Q4 24
-54.1%
-80.1%
Q3 24
-70.6%
-131.0%
Q2 24
-102.8%
-172.7%
Q1 24
-155.0%
-197.4%
Net Margin
RCEL
RCEL
RUM
RUM
Q4 25
-66.0%
-120.8%
Q3 25
-77.3%
-65.7%
Q2 25
-53.9%
Q1 25
-74.9%
-11.2%
Q4 24
-63.0%
-783.2%
Q3 24
-82.9%
-125.9%
Q2 24
-101.3%
-119.2%
Q1 24
-168.0%
-244.1%
EPS (diluted)
RCEL
RCEL
RUM
RUM
Q4 25
$-0.37
$-0.13
Q3 25
$-0.46
$-0.06
Q2 25
$-0.38
Q1 25
$-0.53
$-0.01
Q4 24
$-0.44
$-1.17
Q3 24
$-0.62
$-0.15
Q2 24
$-0.60
$-0.13
Q1 24
$-0.73
$-0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RCEL
RCEL
RUM
RUM
Cash + ST InvestmentsLiquidity on hand
$18.2M
$237.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$-16.6M
$274.8M
Total Assets
$56.4M
$336.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RCEL
RCEL
RUM
RUM
Q4 25
$18.2M
$237.9M
Q3 25
$23.3M
$269.8M
Q2 25
$15.7M
Q1 25
$25.8M
$301.3M
Q4 24
$35.9M
$114.0M
Q3 24
$44.4M
$132.0M
Q2 24
$54.1M
$154.2M
Q1 24
$68.2M
$183.8M
Stockholders' Equity
RCEL
RCEL
RUM
RUM
Q4 25
$-16.6M
$274.8M
Q3 25
$-6.7M
$302.2M
Q2 25
$-12.9M
Q1 25
$-4.6M
$339.6M
Q4 24
$4.5M
$-63.1M
Q3 24
$12.2M
$166.1M
Q2 24
$23.9M
$192.7M
Q1 24
$32.6M
$210.7M
Total Assets
RCEL
RCEL
RUM
RUM
Q4 25
$56.4M
$336.8M
Q3 25
$63.7M
$367.2M
Q2 25
$58.1M
Q1 25
$69.6M
$391.1M
Q4 24
$79.7M
$195.3M
Q3 24
$81.1M
$217.2M
Q2 24
$87.8M
$243.2M
Q1 24
$97.4M
$263.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RCEL
RCEL
RUM
RUM
Operating Cash FlowLast quarter
$-5.4M
$-29.4M
Free Cash FlowOCF − Capex
$-6.1M
$-31.7M
FCF MarginFCF / Revenue
-34.7%
-117.2%
Capex IntensityCapex / Revenue
3.8%
8.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-33.5M
$-70.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RCEL
RCEL
RUM
RUM
Q4 25
$-5.4M
$-29.4M
Q3 25
$-5.2M
$-10.6M
Q2 25
$-10.2M
Q1 25
$-10.3M
$-14.5M
Q4 24
$-8.1M
$-12.4M
Q3 24
$-7.2M
$-19.1M
Q2 24
$-12.8M
$-21.7M
Q1 24
$-20.9M
$-33.9M
Free Cash Flow
RCEL
RCEL
RUM
RUM
Q4 25
$-6.1M
$-31.7M
Q3 25
$-6.2M
$-12.0M
Q2 25
$-10.8M
Q1 25
$-10.5M
$-14.6M
Q4 24
$-9.7M
$-12.4M
Q3 24
$-11.0M
$-19.9M
Q2 24
$-15.4M
$-23.1M
Q1 24
$-22.0M
$-34.3M
FCF Margin
RCEL
RCEL
RUM
RUM
Q4 25
-34.7%
-117.2%
Q3 25
-36.1%
-48.6%
Q2 25
-58.4%
Q1 25
-56.9%
-61.7%
Q4 24
-52.7%
-40.9%
Q3 24
-56.1%
-79.5%
Q2 24
-101.6%
-102.8%
Q1 24
-198.2%
-193.3%
Capex Intensity
RCEL
RCEL
RUM
RUM
Q4 25
3.8%
8.5%
Q3 25
5.5%
5.7%
Q2 25
2.8%
Q1 25
1.2%
0.6%
Q4 24
8.8%
0.1%
Q3 24
19.2%
3.4%
Q2 24
17.5%
6.1%
Q1 24
10.3%
2.4%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

RCEL
RCEL

Segment breakdown not available.

RUM
RUM

Audience Monetization$23.8M88%
Other Initiatives$3.3M12%

Related Comparisons